Related Experiment Video
Updated: Sep 11, 2025

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Pathway-Specific Polygenic Scores for Predicting Clinical Lithium Treatment Response in Patients With Bipolar
Nigussie T Sharew1,2, Scott R Clark1, Sergi Papiol3,4
1Discipline of Psychiatry, School of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
Pathway-specific polygenic scores (PSPGSs) show promise for predicting lithium response in bipolar disorder. These scores offer biological insights and comparable predictive power to traditional genome-wide scores.
Area of Science:
- Psychiatric Genetics
- Pharmacogenomics
- Bipolar Disorder Research
Background:
- Polygenic scores (PGSs) can predict treatment response in psychiatry, but their biological basis is often unclear.
- Developing pathway-specific PGSs (PSPGSs) may improve biological interpretability for psychiatric treatment response.
- This study focuses on lithium response in bipolar disorder, a critical area for personalized medicine.
Purpose of the Study:
- To develop and evaluate pathway-specific polygenic scores (PSPGSs) for predicting lithium response in bipolar disorder patients.
- To assess the biological interpretability and predictive performance of PSPGSs compared to conventional PGSs.
- To identify specific biological pathways associated with lithium response.
Main Methods:
- Developed 9 pathway-specific PGSs (PSPGSs) using genes from lithium-affected pathways.
- Evaluated PSPGSs associations with lithium response (categorical and continuous) in a large cohort (ConLi+Gen, N=2367) and validated in two smaller cohorts.
- Used regression models, adjusting for confounders, with stringent statistical significance thresholds (p < .05 after multiple testing correction).
Main Results:
- PSPGSs for acetylcholine, GABA, and mitochondria were significantly associated with lithium response (categorical and continuous outcomes).
- PSPGSs for calcium channel, circadian rhythm, and GSK were associated with continuous lithium response.
- A combined PSPGS model explained up to 3.71% of the variance in lithium response, with acetylcholine variants showing a 3.03-fold increased likelihood of good response in the highest genetic loading group.
Conclusions:
- Pathway-specific PGSs (PSPGSs) demonstrate comparable predictive performance to genome-wide PGSs for lithium response.
- PSPGSs offer enhanced biological interpretability by utilizing a focused set of genetic variants.
- These findings support the potential of PSPGSs for personalized treatment selection in bipolar disorder.
More Related Videos
08:33Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
Published on: December 4, 2014
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Related Concept Videos
Mania and Antimanic Drugs: Overview
Bipolar Disorder
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Polygenic Traits
Psychosis: Goals of Pharmacotherapy
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...